BIOEN vs RUZYE Comparison
Price, market cap, valuation, profitability and leverage metrics of BIOEN and RUZYE side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | BIOEN | RUZYE | Sector median |
|---|---|---|---|
| Last price (TL) | 9.30 | 4.82 | 20.41 |
| Daily change | −8.82% | −6.95% | −5.69% |
| Market cap | TRY 4.7B | TRY 1.3B | TRY 10.8B |
| P/B | 1.56 | 0.85 | 1.09 |
| Return on equity | −23.95% | −8.31% | 4.43% |
| Free float | 52.11% | 67.09% | 26.02% |
Popular comparisons
Related pages
About the BIOEN vs RUZYE comparison
Price, market cap, valuation multiples, profitability and leverage of BIOEN (Biotrend Cevre ve Enerji) and RUZYE (Ruzy Madencilik ve Enerji) side by side as of Sep 28, 2026, 11:42. Of the 14 metrics compared, BIOEN leads in 6 and RUZYE leads in 8.
Highlights: Daily change: RUZYE leads (−6.95% vs −8.82%). Market cap: BIOEN leads (TRY 4.7B vs TRY 1.3B). P/B: RUZYE leads (0.85 vs 1.56). EV/EBITDA: BIOEN leads (85.99 vs −192.10). EV/Sales: BIOEN leads (7.58 vs 8.57). Gross margin: BIOEN leads (−7.36% vs −31.85%). EBITDA margin (annual): BIOEN leads (5.02% vs −1.79%). Net margin (annual): BIOEN leads (−34.61% vs −54.70%).
Frequently asked questions
Is BIOEN or RUZYE cheaper?
By P/E, Tie is cheaper (— vs —); by P/B, RUZYE trades at the lower multiple (1.56 vs 0.85).
Which is more profitable, BIOEN or RUZYE?
Annual net margin is −34.61% for BIOEN and −54.70% for RUZYE; return on equity is −23.95% for BIOEN and −8.31% for RUZYE.
Which is more leveraged, BIOEN or RUZYE?
The leverage ratio is 71.76 for BIOEN and 22.91 for RUZYE; net debt/EBITDA is 46.35 for BIOEN and — for RUZYE. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.